Treatment > Etoposide (VP-16)


Astrocytomas


E. Lopez Aguilar, S. Delgado-Huerta, A. C. Sepulveda-Vildosola, V. Wanzke-Del-angel, H. Rodriguez-Jimenez
Neoadjuvant chemotherapy with temozolamide plus ifosfamide, carboplatin and etoposide in pediatric patients with high grade astrocytomas. Phase II study
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
 


Brain Tumors


Fiorillo A, Maggi G, Greco N, Migliorati R, D'Amico A, De Caro MD, Sabbatino MS, Buffardi F
Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors
J Neurooncol. 2004 Jan;66(1-2):179-85. 

Cheppail Ramachandran, Ziad Khatib, Athena Pefkarou, John Fort, Hugo B. Fonseca, Steven J. Melnick and Enrique Escalon
Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells
J Neurooncol. 2004 Mar-Apr;67(1-2):19-28. (Abstract+)

Terasaki M, Bouffet E, Katsuki H, Fukushima S, Shigemori M.
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors
Surg Neurol. 2008 Jan;69(1):46-50
 Abstract |
DBLinks | BL 7:6


Embryonal Tumors


H. Shirato, J. Ikeda, H. Aoyama, N. Ishii, T. Taguchi, T. Kato, M. Tada, Y. Sawamura
Low-dose craniospinal irradiation and ifosfamide, cisplatine, and etoposide for embryonal tumors in central nervous system
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 430 


Germ Cell Tumors


Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53. 


Glioblastoma


C. F. Classen, M. Warmuth-Metz, K. Papke, A. Trotter, J. E. A. Wolff, S. Wagner
Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols
Pediatr Hematol Oncol. 2006 Dec;23(8):631-7. DOI: 10.1080/08880010600951088

E. Schuller, R. Seidl, C. Wandl, K. Dieckmann, I. Slavc
Prolonged Second Response To Cisplatin, Etoposide, And Ifosfamide In A Child With A Recurrent Brainstem Glioblastoma
Pediatric Hematology and Oncology, Volume 18, Number 4/June 1, 2001, 253 - 258
 Abstract | DBLinks | BL 1:3

J. M. Simon, G. Noel, K. Hoang-Xuan, A. F. Carpentier, K. Mokhtari, S. Racadot, F. Baillet, J. J. Mazeron
Radiotherapy and concomitant weekly carboplatin and daily etoposide for patients with inoperable biopsy proven glioblastoma multiforme
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1544 


Glioma


Benyahia B, Huguet S, Decleves X, Mokhtari K, Criniere E, Bernaudin JF, Scherrmann JM, Delattre JY
Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1
J Neurooncol. 2004 Jan;66(1-2):65-70. 

Bourg V, Lebrun C, Chichmanian RM, Thomas P, Frenay M
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity
Ann Oncol 2001 Feb;12(2):217-9 


Glioma (High-Grade)


Lynn G. Feun, Angela Marini, Howard Landy, Arnold Markoe, Deborah Heros, Carlos Robles, Cristina Herrera and Niramol Savaraj
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors
J Neurooncol. 2006 Oct 19; [Epub ahead of print]
Abstract

D. Korones, M. Benita-Weiss, T. E. Coyle, P. Bushunow, L. Mechtler, H. S. Friedman
A phase II trial of temozolomide and oral VP-16 for adults with recurrent malignant glioma
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 447 

Korones DN, Benita-Weiss M, Coyle TE, Mechtler L, Bushunow P, Evans B, Reardon DA, Quinn JA, Friedman H
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma
Cancer 2003 Apr 15;97(8):1963-8 

David N Korones, Michal Benita-Weiss, Lazlo Mechtler, Peter Bushunow, Brandon L Evans, Henry S Friedman
A phase I study of temozolomide (Temodar) and escalating doses of oral VP-16 for adults with recurrent malignant glioma
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No. 2080  

David N Korones, Michal Benita-Weiss, Lazlo Mechtler, Peter Bushunow, Henry S Friedman
A Phase 1 Study of Temozolomide (Temodar) and Escalating Doses of Oral VP-16 for Adults with Recurrent Malignant Gliomas
ASCO Proceedings, 2001 Annual Meeting, Abstract No. 2055 



Gliomas (Low-Grade)


Mee Jeong Lee, Young Shin Ra, Jun Bum Park, Hyun Woo Goo, Seung Do Ahn, Shin Kwang Khang, Joon Sup Song, Yoon Jung Kim and Thad T. Ghim
Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children
Journal of Neuro-Oncology, Volume 80, Number 3 / December, 2006, Pages 277-284, Published online: 29 June 2006


Medulloblastoma


F. Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P. Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival results in adults treated for medulloblastoma
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 479 



Metastatic Tumors


Jane W. Marsh, Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January 2004. (Abstract+)


Oligo Tumors & Mixed Gliomas


L. Scopece, G. Cavallo, E. Palmerini, E. Franceschi, A. Paioli, F. Spagnolli, S. Rimondini, R. Conforti, R. Degli Esposti, L. Crino
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1562 


Pediatric Brain Tumors


Maura Massimino, Lorenza Gandola, Roberto Luksch, Filippo Spreafico, Daria Riva, Carlo Solero, Felice Giangaspero, Franco Locatelli, Marta Podda, Fabio Bozzi, Emanuele Pignoli, Paola Collini, Graziella Cefalo, Marco Zecca, Michela Casanova, Andrea Ferrari, Monica Terenziani, Cristina Meazza, Daniela Polastri, Davide Scaramuzza, Fernando Ravagnani, and Franca Fossati-Bellani
Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma
Neuro-Oncology,
Volume 7, Number 1, Pages 41 -- 48, January 2005. (Abstract+)

 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP